{"DataElement":{"publicId":"4379839","version":"1","preferredName":"Laboratory Procedure Within Clinical Study Protocol Upper Limit of Normal Total Bilirubin Measurement Code Indicator","preferredDefinition":"The coded yes/no/not applicable indicator related to the top value of the range for total bilirubin falling within parameters set forth by the guidelines for a clinical trial.","longName":"LAB_TBM_CD_IND","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"2603677","version":"1","preferredName":"Laboratory Procedure Within Clinical Study Protocol Upper Limit of Normal Total Bilirubin Measurement","preferredDefinition":"information related to the top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for total bilirubin, bilirubin is a breakdown product of hemoglobin and total bilirubin is measured to screen for or to monitor liver or gall bladder dysfunction, falling within parameters set forth by the action plan and guidelines for a clinical trial.","longName":"LAB_W_PRO_ULN_TTLBIL","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2780801","version":"1","preferredName":"Within Clinical Study Protocol Upper Limit of Normal Total Bilirubin Measurement","preferredDefinition":"On the inside; contained in.:An action plan for a clinical trial.  The plan states what the study will do, how, and why.  It explains how many people will be in it, who is eligible to participate, what study agents or other interventions they will be given, what tests they will receive and how often, and what information will be gathered.:The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.:Bilirubin is a breakdown product of hemoglobin. Total and direct bilirubin are usually measured to screen for or to monitor liver or gall bladder dysfunction. (from MedlinePlus Medical Encyclopedia)","longName":"C25282:C25320:C25706:C38037","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Within","conceptCode":"C25282","definition":"On the inside; contained in.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Clinical Study Protocol","conceptCode":"C25320","definition":"A formal document that describes a complete plan of research activity in the framework of a clinical study; specifically, the study objective(s), design, methodology, eligibility requests for prospective subjects and controls; intervention regimen(s), proposed methods of analysis of data; statistical considerations, and organization of the study. The protocol usually also provides the background and rationale for the study, but these could be represented in other protocol referenced documents.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Upper Limit of Normal","conceptCode":"C25706","definition":"The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Total Bilirubin Measurement","conceptCode":"C38037","definition":"The measurement of the total amount of bilirubin present in a particular substrate. The substrate most often tested is blood, but other fluids extracted from the body may be used periodically depending on the purpose of the test.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"5665CCC0-A68F-4535-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-09-08","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-09-08","modifiedBy":"ONEDATA","dateModified":"2008-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2A7B03CB-45F0-3315-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2007-02-27","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2007-02-27","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3298541","version":"1","preferredName":"Yes No Not Applicable Code Indicator","preferredDefinition":"Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.","longName":"YES_NO_NA_CD_IND","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"X","valueDescription":"Not applicable","ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B04AC04D-C223-0627-E040-BB89AD432C31","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"ONEDATA","dateModified":"2011-10-27","deletedIndicator":"No"},{"value":"N","valueDescription":"No","ValueMeaning":{"publicId":"2559515","version":"1","preferredName":"No","longName":"2559515","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B588-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B04AC04D-C22D-0627-E040-BB89AD432C31","beginDate":"2002-08-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"ONEDATA","dateModified":"2011-10-27","deletedIndicator":"No"},{"value":"Y","valueDescription":"Yes","ValueMeaning":{"publicId":"2560453","version":"1","preferredName":"Yes","longName":"2560453","preferredDefinition":"The affirmative response to a question or activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B932-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CLOHNES","dateModified":"2023-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B04AC04D-C237-0627-E040-BB89AD432C31","beginDate":"2002-08-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"ONEDATA","dateModified":"2011-10-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3298540","version":"1","preferredName":"Yes No Not Applicable Code Indicator","preferredDefinition":"The affirmative response to a question or activity.:The non-affirmative response to a question.:Determination that a value is not relevant in the current context.:A system of numbered categories for representation of data.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"3298540v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B04AC04D-C1F2-0627-E040-BB89AD432C31","latestVersionIndicator":"Yes","beginDate":"2011-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"ONEDATA","dateModified":"2011-10-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTMS:Clinical Trials Monitoring Service","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B04AC04D-C203-0627-E040-BB89AD432C31","latestVersionIndicator":"Yes","beginDate":"2011-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"MAESKEB","dateModified":"2016-01-20","changeDescription":"Created to support Theradex design of CRFs for NCI CCR trials","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3876352","version":"1","longName":"Inclusion Criteria","context":"Theradex","ClassificationSchemeItems":[{"publicId":"3876425","version":"1","longName":"Laboratory Data (including serologic/viral status)","context":"Theradex"}]},{"publicId":"3876594","version":"1","longName":"Theradex","context":"Theradex","ClassificationSchemeItems":[{"publicId":"3876603","version":"1","longName":"Theradex - CTMS 3.14","context":"Theradex"}]}],"AlternateNames":[{"name":"LAB_TBM_CD_IND","type":"USED_BY","context":"Theradex"},{"name":"NRG","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Theradex - 2","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than 1.5 x the upper limit of normal for the institution?","url":null,"context":"Theradex"},{"name":"Theradex - 3","type":"Alternate Question Text","description":"Is pre-study serum total bilirubin less than or equal to 1.5 X upper limit of normal (ULN) OR direct bilirubin less than or equal to ULN for patients with total bilirubin levels greater than 1.5 ULN?","url":null,"context":"Theradex"},{"name":"Is pre study serum bilirubin","type":"Preferred Question Text","description":"Is pre study serum bilirubin less than 1.5 x upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 5","type":"Alternate Question Text","description":"Is pre-study total bilirubin within normal institutional limits?","url":null,"context":"Theradex"},{"name":"Theradex - 4","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.25 x institutional upper limit of normal, with the exception of less than 2.9 mg/dL for patients with Gilbert's disease?","url":null,"context":"Theradex"},{"name":"Theradex - 6","type":"Alternate Question Text","description":"Is pre-study serum total bilirubin less than 2 x upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 7","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x the upper limit of normal for the institution?","url":null,"context":"Theradex"},{"name":"Theradex - 8","type":"Alternate Question Text","description":"Is pre study serum bilirubin less than or equal to 1.5 x upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 12","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal OR is direct bilirubin within normal range if pre-study total bilirubin greater than 1.5 x institutional upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 10","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 2.0 x the institutional upper limit normal?","url":null,"context":"Theradex"},{"name":"Theradex - 13","type":"Alternate Question Text","description":"Is pre-study bilirubin less than 1.5 x institutional upper limit of normal or less than 2.5 x upper limit of normal if liver metastases?","url":null,"context":"Theradex"},{"name":"Theradex - 11","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal, less than or equal 3.0 x upper limit of normal if due to Gilbert's syndrome or hemolysis?","url":null,"context":"Theradex"},{"name":"Theradex - 16","type":"Alternate Question Text","description":"Is pre study total bilrubin less than or equal to 1.5 x upper limit of normal of patient has known Gilbert's disease or similar syndrome with slow conjugation of bilirubin is total bilirubin less than or equal to 3.0 mg/dL?","url":null,"context":"Theradex"},{"name":"Theradex - 15","type":"Alternate Question Text","description":"Is pre-study total bilirubin below institutional upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 17","type":"Alternate Question Text","description":"Is pre study total bilirubin less than or equal to 1.5 x upper limit of normal or if patient has known Gilbert's disease or similar syndrome with slow conjugation of bilirubin is total bilirubin less than or equal to 3.0 mg/dL?","url":null,"context":"Theradex"},{"name":"Theradex - 14","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x upper limit of normal, unless Gilbert's syndrome or disease infiltration of the liver is present?","url":null,"context":"Theradex"},{"name":"Theradex - 18","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x upper limit of normal (ULN) (however, patients with known Gilbert disease who have serum bilirubin level less than or equal to 3 X ULN may be enrolled)?","url":null,"context":"Theradex"},{"name":"Theradex - 23","type":"Alternate Question Text","description":"Is pre-study total bilirubin total bilirubin less than or equal to 2.0 mg/dL (except patients with Gilbert Syndrome, who can have total bilirubin less than 3.0 mg/dL)?","url":null,"context":"Theradex"},{"name":"Theradex - 22","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x local institutional upper limit of normal (ULN) OR if total bilirubin is elevated due Gilbert's disease or disease-related hemolysis then is total bilirubin less than or equal to 3.0 x local institutional ULN?","url":null,"context":"Theradex"},{"name":"Theradex - 21","type":"Alternate Question Text","description":"Is pre study serum bilirubin less than 1.5 x institutional upper limit of normal (with the exception of those with Gilbert syndrome)?","url":null,"context":"Theradex"},{"name":"Theradex - 19","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x upper limit of normal, except for patients with Gilbert syndrome ALT less than or equal to 3.0 x upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 20","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x upper limit of normal (patients with Gilbert's syndrome may have serum bilirubin greater than 1.5 x upper limit of normal)?","url":null,"context":"Theradex"},{"name":"Theradex - 27","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal if no demonstrable liver metastases or less than or equal to 3 x institutional upper limit of normal in the presence of liver metastases or Gilbert's Syndrome (unconjugated hyperbilirubinemia)?","url":null,"context":"Theradex"},{"name":"Theradex - 44","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x upper limit of normal (ULN) (however, patients with known Gilbert disease who have serum bilirubin level less than or equal to 3 X ULN may be enrolled), within 2 weeks of randomization?","url":null,"context":"Theradex"},{"name":"Theradex - 25","type":"Alternate Question Text","description":"Total bilirubin less than or equal to 2.0 mg/dL unless due to Gilbert's syndrome, hemolysis, or ineffective hematopoiesis?","url":null,"context":"Theradex"},{"name":"Theradex - 24","type":"Alternate Question Text","description":"Is pre study total bilirubin less than 1.5 x upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 26","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x upper limit of normal, except for patients with Gilbert syndrome; ALT less than or equal to 3.0 x upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 30","type":"Alternate Question Text","description":"Is pre study total bilirubin less than or equal to 1.5 x upper limit of normal or if patient has known Gilbert's disease or similar syndrome with slow conjugation of bilirubin is total bilirubin less than or equal to 3.0 mg/dL?","url":null,"context":"Theradex"},{"name":"Theradex - 32","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to the institution's upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 31","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x upper limit of normal (patients with Gilbert's syndrome may have direct bilirubin more than 1.5 x upper limit of normal)?","url":null,"context":"Theradex"},{"name":"Theradex - 33","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than 1.5 x institutional upper limit of normal (ULN) (less than 2.0 x ULN for subjects with documented Gilbert's syndrome or less than  3.0 x ULN for subjects for whom the indirect bilirubin level suggests an extra-hepatic source of elevation)?","url":null,"context":"Theradex"},{"name":"Theradex - 35","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal if no demonstrable liver metastases or less than or equal to 3 x institutional upper limit of normal in the presence of liver metastases or Gilbert's Syndrome (unconjugated hyperbilirubinemia)?","url":null,"context":"Theradex"},{"name":"Theradex - 28","type":"Alternate Question Text","description":"Is pre-study serum bilirubin less than or equal to 1.5 x institutional upper limit of normal (except patients with Gilberts syndrome who can have total bilirubin less than 3 mg/dl)?","url":null,"context":"Theradex"},{"name":"Theradex - 34","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x upper limit of normal, except for patients with Gilbert syndrome?","url":null,"context":"Theradex"},{"name":"Theradex - 29","type":"Alternate Question Text","description":"Is pre-study serum total bilirubin less than or equal to upper limit of normal (ULN) OR direct bilirubin less than or equal to ULN for patients with total bilirubin levels greater than ULN; (except patients with Gilbert's Syndrome, who must have a total bilirubin less than 3.0 mg/dL)?","url":null,"context":"Theradex"},{"name":"Theradex - 38","type":"Alternate Question Text","description":"Is pre-study serum bilirubin within normal limits (WNL) or less than or equal to 1.5 x ULN in patients with liver metastases; or total bilirubin less than or equal to 3.0 x ULN with direct bilirubin WNL in patients with documented Gilbert's Syndrome?","url":null,"context":"Theradex"},{"name":"Theradex - 39","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than 1.5 x institutional upper limit of normal (ULN) (less than 2.0 x ULN for patients with documented Gilbert's syndrome or less than  3.0 x ULN for subjects for whom the indirect bilirubin level suggests an extra-hepatic source of elevation)?","url":null,"context":"Theradex"},{"name":"Theradex - 37","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (except patients with Gilberts syndrome who can have total bilirubin less than 3 mg/dl)?","url":null,"context":"Theradex"},{"name":"Theradex - 40","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than 1.5 x institutional upper limit of normal or less than 2.5 x upper limit of normal if patient is know to have liver metastases?","url":null,"context":"Theradex"},{"name":"Theradex - 41","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than 1.5 x institutional upper limit of normal (ULN) (less than 2.0 x ULN for subjects with documented Gilbert's syndrome or less than 3.0 x ULN for subjects for whom the indirect bilirubin levels suggests an extrahepatic source of elevation)?","url":null,"context":"Theradex"},{"name":"Theradex - 43","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than 1.5 x institutional upper limit of normal OR greater than 1.5 x institutional upper limit of normal is allowed if direct bilirubin is within normal range?","url":null,"context":"Theradex"},{"name":"Theradex - 45","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN) (however, patients with known Gilbert disease who have serum bilirubin level less than or equal to 3 X ULN may be enrolled), within 2 weeks of randomization?","url":null,"context":"Theradex"},{"name":"Theradex - 36","type":"Alternate Question Text","description":"Is pre-study serum bilirubin less than or equal to 1.5 x institutional upper limit of normal (except patients with Gilbert's syndrome who can have total bilirubin less than 3 mg/dl)?","url":null,"context":"Theradex"},{"name":"Theradex - 42","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than 1.5 x institutional upper limit of normal or less than 2.5 x upper limit of normal if patient is know to have liver metastases?","url":null,"context":"Theradex"},{"name":"Theradex - 47","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x the institutional upper limit of normal within 28 days prior to administration of therapy?","url":null,"context":"Theradex"},{"name":"Theradex - 50","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN) (however, patients with known Gilbert disease who have serum bilirubin level less than or equal to 3 X ULN may be enrolled)?","url":null,"context":"Theradex"},{"name":"Theradex - 46","type":"Alternate Question Text","description":"Is pre-study total bilirubin within normal institutional limits OR if patient has confirmed Gilbert's syndrome is total bilirubin less than or equal to 2.0 x ULN?","url":null,"context":"Theradex"},{"name":"Theradex - 51","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 2.0 mg/dL (except patients with Gilbert Syndrome, who can have total bilirubin less than 3.0 mg/dL)?","url":null,"context":"Theradex"},{"name":"Theradex - 48","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x upper limit of normal, unless due to Gilbert syndrome?","url":null,"context":"Theradex"},{"name":"Theradex - 49","type":"Alternate Question Text","description":"Is pre-study total bilirubin within normal institutional limits (WLN) or less than or equal to 1.5 x upper limit of normal (ULN) in patients with liver metastases; or total bilirubin less than or equal to 3 x ULN with direct bilirubin WLN in patients with well documented Gilbert's syndrome?","url":null,"context":"Theradex"},{"name":"Theradex -  53","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than 2.0 unless due to Gilbert's Syndrome?","url":null,"context":"Theradex"},{"name":"Theradex - 52","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x upper limit of normal (ULN) (or if patient has known Gilbert disease is serum bilirubin level less than or equal to 3 X ULN)?","url":null,"context":"Theradex"},{"name":"Theradex - 55","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than 2.0 mg/dL unless due to Gilbert's Syndrome then less than 5.0 mg/dL?","url":null,"context":"Theradex"},{"name":"Theradex - 54","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN) (however, patients with known Gilbert disease who have serum bilirubin level less than or equal to 3 X ULN may be enrolled)?","url":null,"context":"Theradex"},{"name":"Theradex - 65","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to the upper limit of normal (except in Gilbert's syndrome)?","url":null,"context":"Theradex"},{"name":"Theradex - 57","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than institutional upper limit of normal or less than 3X the upper limit of normal in patients with Gilbert's disease?","url":null,"context":"Theradex"},{"name":"Theradex - 66","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal, unless the subject has known or suspected Gilbert's syndrome?","url":null,"context":"Theradex"},{"name":"Theradex - 56","type":"Alternate Question Text","description":"Is pre-study serum bilirubin less than or equal to 1.5 x upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 61","type":"Alternate Question Text","description":"Is pre-study total bilirubin within institutional upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 63","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than to 2 x upper limit of normal (patients with Gilbert's syndrome may have direct bilirubin more than 2.5 x upper limit of normal)?","url":null,"context":"Theradex"},{"name":"Theradex - 58","type":"Alternate Question Text","description":"Is pre-study total bilirubin below or within normal institutional limits?","url":null,"context":"Theradex"},{"name":"Theradex - 64","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (less than or equal to 3 x institutional upper limit of normal for patients with Gilbert syndrome), within 7 days before starting treatment?","url":null,"context":"Theradex"},{"name":"Theradex - 62","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x upper limit of normal (ULN) (or if patient has documented Gilbert's disease is total bilirubin level less than or equal to 3 mg/dL)?","url":null,"context":"Theradex"},{"name":"Theradex - 60","type":"Alternate Question Text","description":"Is pre-study serum bilirubin less than upper limit (ULN) of normal or less than 1.5 x  upper limit of normal (ULN) in patients with liver metastases or total bilirubin less than 3.0 x upper limit of normal (ULN) with direct bilirubin within normal limits (WNL) in patients with well documented Gilbert's Syndrome?","url":null,"context":"Theradex"},{"name":"Theradex - 59","type":"Alternate Question Text","description":"Is pre study total bilirubin less than or equal to 1.5 x the institutional upper limit of normal or less than or equal to 3.0 mg/dL if patient has Gilbert's disease?","url":null,"context":"Theradex"},{"name":"Theradex - 67","type":"Alternate Question Text","description":"Is pre study total bilirubin less than or equal to 1.5 x the institutional upper limit of normal or less than 3.0 mg/dL if patient has Gilbert's disease?","url":null,"context":"Theradex"},{"name":"Theradex - 68","type":"Alternate Question Text","description":"Is screening visit total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN) (however, patients with known Gilbert`s disease who have serum bilirubin level less than or equal to 3 x ULN may be enrolled)?","url":null,"context":"Theradex"},{"name":"Theradex - 70","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x upper limit of normal (except patients with Gilberts syndrome who can have total bilirubin less than 3 mg/dl)?","url":null,"context":"Theradex"},{"name":"Theradex - 71","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than 2 times the upper limit of institutional normal (ULN) unless due to Gilbert's disease or thought to be related to the underlying disease?","url":null,"context":"Theradex"},{"name":"Theradex - 69","type":"Alternate Question Text","description":"Is pre-study serum total bilirubin less than 2 x institutional upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 72","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to the institutional upper limit of normal (ULN) except for patients with Gilbert's syndrome or post-transfusion hemolysis who may enroll if direct bilirubin is less than or equal to 1.5 x ULN of the direct bilirubin?","url":null,"context":"Theradex"},{"name":"Theradex - 73","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than 1.5 X institutional upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 75","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x the upper limit of normal (ULN) for the institution?","url":null,"context":"Theradex"},{"name":"Theradex - 78","type":"Alternate Question Text","description":"If patient does not have Gilbert syndrome, is pre-study total bilirubin less than 1.5 x institutional upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 77","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to the institutional upper limit of normal (ULN) except for patients with Gilbert's syndrome hemolysis who may enroll if direct bilirubin is less than or equal to 1.5 x ULN for the laboratory of the direct bilirubin?","url":null,"context":"Theradex"},{"name":"Theradex - 79","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to the institutional upper limit of normal (ULN), except for patients with Gilbert's syndrome who may enroll if direct bilirubin is less than or equal to 1.5 x ULN for the laboratory?","url":null,"context":"Theradex"},{"name":"Theradex - 80","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to the institutional upper limit of normal (ULN)?","url":null,"context":"Theradex"},{"name":"Theradex - 74","type":"Alternate Question Text","description":"Is pre-study bilirubin less than or equal to the institutional upper limit of normal (ULN) except for patients with Gilbert's syndrome who may enroll if direct bilirubin is less than or equal to 1.5 x ULN?","url":null,"context":"Theradex"},{"name":"Theradex - 76","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x ULN (less than 3 x ULN for patients with Gilbert syndrome, patients with cholestasis due to compressive adenopathies of the hepatic hilum or documented liver involvement)?","url":null,"context":"Theradex"},{"name":"Theradex - 88","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (less than or equal to 3.0 x upper limit of normal for patients with Gilbert syndrome)?","url":null,"context":"Theradex"},{"name":"Theradex - 84","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x upper limit of normal or direct bilirubin less than or equal to upper limit of normal for patients with total bilirubin levels greater than 1.5 x upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 82","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x the institutional upper limit of normal or less than 3X the upper limit of normal for indirect bilirubin in patients with Gilbert's disease?","url":null,"context":"Theradex"},{"name":"Theradex - 83","type":"Alternate Question Text","description":"Are pre-study total bilirubin and serum bilirubin less than or equal to 1.5 x the institutional upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 85","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 2.0 mg/dL?","url":null,"context":"Theradex"},{"name":"Theradex - 86","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than 2.0 mg/dL unless due to Gilbert's Syndrome then less than 5.0 mg/dL?","url":null,"context":"Theradex"},{"name":"Theradex - 87","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal or up to 3 mg/dL for patients with Gilberts disease?","url":null,"context":"Theradex"},{"name":"Theradex - 90","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1 x the institutional upper limit of normal except for patients with Gilbert's syndrome who may enroll if direct bilirubin is less than or equal to 1.5 x ULN?","url":null,"context":"Theradex"},{"name":"Theradex - 91","type":"Alternate Question Text","description":"Is pre-study serum bilirubin less than or equal to 1.5 x institutional upper limit of normal (for patients with hemolysis, Gilbert's syndrome or liver infiltration with leukemia is serum bilirubin less than or equal to 3 x upper limit of normal)?","url":null,"context":"Theradex"},{"name":"Theradex - 92","type":"Alternate Question Text","description":"Is pre-study serum total bilirubin less than or equal to 1.5 X upper limit of normal (ULN) OR direct bilirubin less than or equal to ULN for patients with total bilirubin levels greater than 1.5  x ULN or serum bilirubin less than or equal to 3 x upper limit of normal for patients with known Gilberts disease?","url":null,"context":"Theradex"},{"name":"Theradex - 89","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x the institutional upper limit of normal, except for patients with Gilbert syndrome who have less than or equal to 3 x the institutional upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 96","type":"Alternate Question Text","description":"Is pre-study serum bilirubin less than 1.5 x institutional upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 9","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than 1.5 X upper limit of normal (ULN); or less than 3 x institutional ULN for Gilbert's syndrome or HIV protease inhibitors; or less than 5 x ULN and direct bilirubin less than 0.7 mg/dL for patients on atazanavir containing HIV regimen?","url":null,"context":"Theradex"},{"name":"Theradex - 95","type":"Alternate Question Text","description":"Is pre-study serum total bilirubin less than or equal to 1.5 X upper limit of normal (ULN) OR direct bilirubin less than or equal to ULN for patients with total bilirubin levels greater than 1.5 x ULN?","url":null,"context":"Theradex"},{"name":"Theradex - 94","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal, for age?","url":null,"context":"Theradex"},{"name":"Theradex - 81","type":"Alternate Question Text","description":"Is pre-study serum bilirubin less than or equal to 1.5 x institutional upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 100","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 X institutional upper limit of normal (less than or equal to 3 x upper limit of normal in the presence of documented Gilbert's syndrome or liver metastases at baseline), within 8 days of enrollment?","url":null,"context":"Theradex"},{"name":"Theradex - 97","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal, unless the patient has Gilberts disease?","url":null,"context":"Theradex"},{"name":"Theradex - 101","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 X upper limit of normal (ULN)?","url":null,"context":"Theradex"},{"name":"Theradex - 98","type":"Alternate Question Text","description":"Is pre-study serum bilirubin within normal limits (WNL) or less than or equal to 1.5 X ULN in patients with liver metastases, or is total bilirubin less than or equal to 3 X ULN with direct bilirubin WNL in patients with well-documented Gilbert's Syndrome (within 7 days of study drug initiation)?","url":null,"context":"Theradex"},{"name":"NRG_eCRF_Text","type":"Alternate Question Text","description":"Has the patient had bilirubin less than or equal to 1.5 x ULN within 14 days prior to enrollment?","url":null,"context":"NRG"},{"name":"Theradex - 102","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 2 x the institutional upper limit of normal (ULN)?","url":null,"context":"Theradex"},{"name":"Theradex - 103","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 2 mg/dl, unless from hemolysis, Gilbert's syndrome or liver infiltration with leukemia?","url":null,"context":"Theradex"},{"name":"Theradex - 104","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 3 x the institutional upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 93","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x the upper limit of normal or direct bilirubin less than or equal to upper limit of normal for subjects with total bilirubin levels greater than 1.5 x upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 105","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to institutional upper limit of normal (ULN)  OR serum bilirubin less than or equal to 3x ULN for patients with known Gilbert disease?","url":null,"context":"Theradex"},{"name":"Theradex - 107","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN) except for subjects with Gilbert's syndrome or genetic equivalent?","url":null,"context":"Theradex"},{"name":"Theradex - 109","type":"Alternate Question Text","description":"Is pre-study serum bilirubin less than or equal to 1.5x institutional upper limit of normal (ULN) except subjects with known Gilbert's syndrome?","url":null,"context":"Theradex"},{"name":"Theradex - 114","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x upper limit of normal if no liver metastases or less than 3 x ULN if patient has Gilbert's Syndrome or liver metastases at baseline?","url":null,"context":"Theradex"},{"name":"Theradex - 115","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x the institutional upper limit of normal or less than or equal to 5 x institutional ULN if patient has history of Gilbert's  syndrome?","url":null,"context":"Theradex"},{"name":"Theradex - 111","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x the institutional upper limit of normal (ULN) and less than 3 x ULN in the presence of documented Gilbert's syndrome or liver metastases at baseline within 14 days of randomization/enrollment?","url":null,"context":"Theradex"},{"name":"Theradex - 112","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 2.5 x institutional upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 113","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x the institutional upper limit of normal for patient age with the exception of those with Gilbert syndrome within 14 days prior to enrollment?","url":null,"context":"Theradex"},{"name":"Theradex - 110","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 2 x institutional upper limit of normal (ULN) for age unless due to Gilbert’s syndrome?","url":null,"context":"Theradex"},{"name":"Theradex - 117","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN) unless due to leukemic infiltration, Gilbert's Syndrome, or hemolysis?","url":null,"context":"Theradex"},{"name":"Theradex - 108","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN); If total bilirubin is greater than 1.5 x ULN, is direct bilirubin less than ULN?","url":null,"context":"Theradex"},{"name":"Theradex - 116","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to institutional upper limit of normal (ULN) except for participants with Gilbert's syndrome or in whom the elevated bilirubinemia is due to ART (must be grade less than or equal to 2)?","url":null,"context":"Theradex"},{"name":"Theradex - 118","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN) OR less than 3 x institutional ULN for patients with Gilbert's syndrome or HIV protease inhibitors?","url":null,"context":"Theradex"},{"name":"Theradex - 119","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 X institutional upper limit of normal (ULN) for age (sum of conjugated and unconjugated)?","url":null,"context":"Theradex"},{"name":"Theradex - 120","type":"Alternate Question Text","description":"Is pre-study direct bilirubin less than or equal to 2 x institutional upper limit of normal (ULN)?","url":null,"context":"Theradex"},{"name":"Theradex - 122","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x the institutional upper limit of normal OR less than or equal to 3 x upper limit of normal in the presence of documented Gilbert's syndrome?","url":null,"context":"Theradex"},{"name":"Theradex - 123","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN) (less than 3 x upper limit of reference range in patients with known/suspected Gilbert's disease)?","url":null,"context":"Theradex"},{"name":"Theradex - 121","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5xULN (institutional upper limit of normal) OR Direct bilirubin less than or equal to ULN for subjects with total bilirubin levels greater than 1.5 x ULN within 14 days prior to treatment?","url":null,"context":"Theradex"},{"name":"Theradex - 125","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 X institutional upper limit of normal (less than or equal to 3 x upper limit of normal in the presence of documented Gilbert's syndrome or liver metastases at baseline)?","url":null,"context":"Theradex"},{"name":"Theradex - 99","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x the upper limit of normal OR direct bilirubin less than or equal to the upper limit of normal for patients with total bilirubin levels greater than 1.5 x the upper limit of normal, within 3 days prior to the first day of 7+3?","url":null,"context":"Theradex"},{"name":"Theradex - 124","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN) OR less than 2.0 x ULN in patients with documented Gilbert's Syndrome?","url":null,"context":"Theradex"},{"name":"Theradex - 128","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN), (less than 3 x ULN in the presence of documented Gilbert's syndrome or liver metastases at baseline), within 14 days of enrollment?","url":null,"context":"Theradex"},{"name":"Theradex - 127","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x the institutional upper limit of normal (less than or equal to 3 x upper limit of normal in the presence of documented Gilbert's syndrome)?","url":null,"context":"Theradex"},{"name":"Theradex - 129","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN) for age OR total bilirubin less than or equal to 2.0 times ULN and direct bilirubin within normal limits for patients with Gilberts syndrome?","url":null,"context":"Theradex"},{"name":"Theradex - 126","type":"Alternate Question Text","description":"Is pre-study serum bilirubin within normal institutional limits (0 - 1.2 mg/dl)?","url":null,"context":"Theradex"},{"name":"Theradex - 130","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x the institution's upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 131","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN); If total bilirubin is greater than 1.5 x ULN, is direct bilirubin less than or equal to ULN?","url":null,"context":"Theradex"},{"name":"Theradex - 132","type":"Alternate Question Text","description":"Is pre-study total bilirubin within 2 weeks of enrollment less than or equal to 1.5 x upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - 133","type":"Alternate Question Text","description":"Is pre study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN) (or less than or equal to 2.0 x ULN in patients with documented Gilbert's Syndrome)?","url":null,"context":"Theradex"},{"name":"Theradex -134","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 2.5 x institutional upper limit of normal unless due to Gilbert's disease, hemolysis, or lymphomatous involvement of liver?","url":null,"context":"Theradex"},{"name":"Theradex - 135","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x the institutional upper limit of normal?","url":null,"context":"Theradex"},{"name":"Theradex - Corrected 134","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN) within 14 days prior to study registration, however, patients with known Gilbert disease who have serum bilirubin level greater than or equal to 3 x ULN may be enrolled?","url":null,"context":"Theradex"},{"name":"Theradex - 136","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal unless due to Gilbert's disease, hemolysis, or lymphomatous involvement of liver, in which case total bilirubin should be less than or equal to 5 x institutional ULN?","url":null,"context":"Theradex"},{"name":"Theradex - 137","type":"Alternate Question Text","description":"Is pre study total bilirubin less than or equal to 1.5x institutional upper limit of normal (ULN)?","url":null,"context":"Theradex"},{"name":"Theradex - 138","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN), except if elevated bilirubin is due to Gilberts disease?","url":null,"context":"Theradex"},{"name":"Theradex - 139","type":"Alternate Question Text","description":"Is pre study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN)?","url":null,"context":"Theradex"},{"name":"Theradex - 140","type":"Alternate Question Text","description":"Is pre-study serum total bilirubin less than or equal to 1.5 x upper limit of normal (ULN), unless considered due to Gilberts disease or disease involvement following approval by the Medical Monitor?","url":null,"context":"Theradex"},{"name":"Theradex - 141","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 2 x institutional upper limit of normal (ULN), except for patients with Gilbert’s syndrome?","url":null,"context":"Theradex"},{"name":"Theradex - 142","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to institutional upper limit of normal (ULN)?","url":null,"context":"Theradex"},{"name":"Theradex - 143","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 x institutional upper limit of normal (ULN) (with the exception of patients with Gilbert syndrome who have a high baseline bilirubin)?","url":null,"context":"Theradex"},{"name":"Theradex - 144","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 mg/dL (excluding Gilberts disease)?","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"FD3B5F10-7826-5EEF-E040-BB89AD4330C9","latestVersionIndicator":"Yes","beginDate":"2014-07-02","endDate":null,"createdBy":"HARTLEYG","dateCreated":"2014-07-02","modifiedBy":"SOKKERL","dateModified":"2024-01-31","changeDescription":"Theradex_ghd_07-02-14 2021-3-29 ak Added AQT.","administrativeNotes":"8/2/2022: fixed the x symbol in AQTs_wz","unresolvedIssues":null,"deletedIndicator":"No"}}